Elizabeth Barrett - Feb 3, 2020 Form 4/A - Amendment Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Executive Officer
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Feb 3, 2020
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/12/2021, 06:57 PM
Date Of Original Report
May 14, 2020
Next filing
Jul 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise +8.81K +7.2% 131K Feb 3, 2020 Direct F1, F2
transaction URGN Ordinary Shares Options Exercise +8.81K +6.72% 140K Mar 3, 2020 Direct F1, F2
transaction URGN Ordinary Shares Options Exercise +8.81K +6.3% 149K Apr 3, 2020 Direct F1, F2
transaction URGN Ordinary Shares Options Exercise +8.81K +5.93% 157K May 3, 2020 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Restricted Stock Units Options Exercise $0 -8.81K -4.17% $0.00 203K Feb 3, 2020 Ordinary Shares 8.81K Direct F1, F2, F3
transaction URGN Restricted Stock Units Options Exercise $0 -8.81K -4.35% $0.00 194K Mar 3, 2020 Ordinary Shares 8.81K Direct F1, F2, F3
transaction URGN Restricted Stock Units Options Exercise $0 -8.81K -4.24% $0.00 199K Apr 3, 2020 Ordinary Shares 8.81K Direct F1, F2, F3
transaction URGN Restricted Stock Units Options Exercise $0 -8.81K -4.76% $0.00 176K May 3, 2020 Ordinary Shares 8.81K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years.